Regulatory standards play a pivotal role in ensuring the safety, efficacy, and quality of veterinary medicinal products (VMPs) across the European Union (EU). Among these standards, Good Distribution Practices (GDP) serve as a cornerstone for the distribution of VMPs and active substances used in their manufacturing. This article delves into the European regulatory framework governing GDP for VMPs and active substances, with a specific focus on the quality system requirements.